We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Proteome Sciences Plc | LSE:PRM | London | Ordinary Share | GB0003104196 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 2.65 | 2.30 | 3.00 | - | 0.00 | 13:55:29 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Biological Pds,ex Diagnstics | 5.03M | -2.44M | -0.0083 | -3.19 | 7.82M |
Date | Subject | Author | Discuss |
---|---|---|---|
12/8/2024 10:22 | LOL just beat me to it jeffian! | elpirata | |
12/8/2024 10:17 | I note that it is so long since the "last tree standing" was felled that the "undergrowth" has started to spring up again! | jeffian | |
12/8/2024 09:46 | Teh #59800 | monte1 | |
12/8/2024 09:46 | Take it Dom. | monte1 | |
12/8/2024 09:46 | Many thanks goatherd. He will be made up. | dominiccummings | |
12/8/2024 09:26 | There are some rather interesting things stirring in the undergrowth about stroke. But, of course, that has happened before fruitlessly. Also similar, but deeper in the undergrowth, about Alzheimer's, which is, of course the real biggy. I would suggest your friend resigns himself to hold for at least another year. And hopes things happen sooner. | goatherd | |
12/8/2024 08:21 | wasjobber ? | monte1 | |
12/8/2024 07:34 | IR-TMT increases mass spec performance by 4 to 5 fold. | pools2 | |
07/8/2024 15:22 | #93001, Well you can't be! 93000 posts (plus a few hundred thousand on other PRM threads) and after 25 years sitting around the all-time low. 'Knowledgeable' posters, my @rse. | jeffian | |
07/8/2024 15:21 | And so he jolly well should be imco. | monte1 | |
07/8/2024 15:17 | You must be very proud! | goatherd | |
07/8/2024 15:02 | thats just open ended gambling | elpirata | |
07/8/2024 13:53 | Maybe. Maybe not. My money is on there is something that will come good. Sometime. | goatherd | |
07/8/2024 13:32 | Thanks pools | glennrcharles | |
07/8/2024 12:52 | Never seen a company with as few rns news announcements, maybe the next one will be a whopper to make up for this and a 25 year wait | the bull | |
07/8/2024 12:45 | All of the testing, 'proving effectiveness and efficacy' has been successfully completed. The UKCA/CE registration is simply a completion of paperwork exercise. | pools2 | |
07/8/2024 12:43 | Re Stoke test. Does CE Registration include proving effectiveness and efficacy? I.e proving that there is a low probability of mis diagnosis. Or has that been done and we are just going through a formal procedure which takes as long as it takes. | glennrcharles | |
07/8/2024 11:49 | What like,Steiner,CJP,Jer | peverill | |
07/8/2024 11:20 | I believe we will find out in due course. | goatherd | |
07/8/2024 09:32 | Mariola has taken nearly 1m in wages,for what exactly??? | peverill | |
05/8/2024 18:37 | I thought I would remind everyone, or perhaps simply those that have forgotten, what the stroke test does, and why it is so important. There are two types of Stroke Ischaemic which is caused by a clot of arteries feeding to, or in, the brain Haemorrhagic which is when an artery or vein in the brain leaks. Haemorrhagic are difficult to treat. However Ischaemic can be treated with a very high success rate (something near 90%) provided a "clot-buster" drug is administered within about 4 hours of the stroke. The problm is that is a clot-buster drug is given to a haemorrhagic stroke victim it will cause them to bleed even more, and s probably kill them. The test Randox has developed, using Proteome biomarkers, tells which type of stroke the patient has had (or, indeed, if they have had only a TIA, or even no stroke), and, crucially, how long ago. Given that information a clot-buster can be administered and around 90% of stroke victims will be returned virtually to normal. About 83% of all strokes (not counting TIAs) are ischaemic so a lot of lives will be saved. High quality lives as well. The drug now being recommended by NICE is tenecteplase, whose price is $8,251.96 per dose. So a $100 diagnostic seems very cheap to me. Much of the information in this post comes from | goatherd |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions